HIV/Hepatitis C Virus−Coinfected Virologic Responders to Pegylated Interferon and Ribavirin Therapy More Frequently Incur Interferon-Related Adverse Events Than Nonresponders Do
暂无分享,去创建一个
M. Proschan | M. Polis | H. Masur | M. McLaughlin | D. Rosenstein | J. Rasimas | R. Bishop | S. Kottilil | A. Osinusi | Alison A. Murphy | K. Cortez